Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 3,000 shares at $83.28 ($250K) on 2021-01-15, disclosed to the SEC on 2021-01-19.
Seasonal sale ($250k) by Director — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |